These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16984012)

  • 1. [Neuromuscular blocking effects of Org 9426 (rocuronium bromide); a comparative study with vecuronium bromide in Japanese patients].
    Shingu K; Masuzawa M; Omote K; Namiki A; Kikuchi H; Kawamada M; Sato S; Kimura T; Hatano N; Nakatsuka H; Morita K; Hara T; Kanmura Y; Takeda J
    Masui; 2006 Sep; 55(9):1140-8. PubMed ID: 16984012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and safety of sugammadex (Org 25969) in reversing moderate neuromuscular block induced by rocuronium or vecuronium in Japanese patients].
    Takeda J; Iwasaki H; Yamakage M; Ozaki M; Kawamata M; Hatano Y; Yorozuya T; Miyakawa H; Kanmura Y
    Masui; 2014 Oct; 63(10):1075-82. PubMed ID: 25693332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and safety of sugammadex (Org 25969) in reversing deep neuromuscular block induced by rocuronium or vecuronium in Japanese patients].
    Takeda J; Iwasaki H; Otagiri T; Katoh T; Shingu K; Obara H; Nakatsuka H; Tomiyama Y; Kasaba T
    Masui; 2014 Oct; 63(10):1083-8. PubMed ID: 25693333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the dose-response and time course of action of rocuronium and vecuronium in anesthetized adult patients.
    Xue FS; Liao X; Liu JH; Tong SY; Zhang YM; Zhang RJ; An G; Luo LK
    J Clin Anesth; 1998 Aug; 10(5):410-5. PubMed ID: 9702623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between mivacurium, rocuronium, and vecuronium during general anesthesia.
    Kim DW; Joshi GP; White PF; Johnson ER
    Anesth Analg; 1996 Oct; 83(4):818-22. PubMed ID: 8831328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
    Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rocuronium priming of atracurium-induced neuromuscular blockade: the use of short priming intervals.
    Abdulatif M; al-Ghamdi A; el-Sanabary M
    J Clin Anesth; 1996 Aug; 8(5):376-81. PubMed ID: 8832448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
    Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
    J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuromuscular blocking effects, pharmacokinetics and safety of Org 9426 (rocuronium bromide) in Japanese patients].
    Suzuki T; Saeki S; Takeda J; Ozaki M; Iwao Y
    Masui; 2006 Apr; 55(4):419-27. PubMed ID: 16634542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of priming with vecuronium and rocuronium on young and elderly patients.
    Aziz L; Jahangir SM; Choudhury SN; Rahman K; Ohta Y; Hirakawa M
    Anesth Analg; 1997 Sep; 85(3):663-6. PubMed ID: 9296427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of neuromuscular action of rocuronium, a new steroidal non-depolarizing agent, with vecuronium.
    Lin PL; Liu CC; Fan SZ; Chao A; Shin SC; Tai YT
    Acta Anaesthesiol Sin; 1997 Sep; 35(3):127-31. PubMed ID: 9407675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of action of vecuronium after an intubating dose of rapacuronium, vecuronium, or succinylcholine.
    Gan TJ; Madan R; Alexander R; Jhaveri R; El-Moalem H; Weatherwax K; Glass PS
    Anesth Analg; 2001 May; 92(5):1199-202. PubMed ID: 11323346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
    Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M
    Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of the differences in the time to onset of action between rocuronium and vecuronium.
    Nava-Ocampo AA; Velázquez-Armenta Y; Moyao-García D; Salmerón J
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):125-30. PubMed ID: 16445711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers.
    Cammu G; De Kam PJ; Demeyer I; Decoopman M; Peeters PA; Smeets JM; Foubert L
    Br J Anaesth; 2008 Mar; 100(3):373-9. PubMed ID: 18238834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromuscular recovery following rocuronium bromide single dose in infants.
    Rapp HJ; Altenmueller CA; Waschke C
    Paediatr Anaesth; 2004 Apr; 14(4):329-35. PubMed ID: 15078379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuromuscular effects of rocuronium under sevoflurane-remifentanil or propofol-remifentanil anesthesia: a randomized clinical comparative study in an Asian population.
    Lee S; Ro YJ; Koh WU; Nishiyama T; Yang HS
    BMC Anesthesiol; 2016 Aug; 16(1):65. PubMed ID: 27549387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous or neostigmine-induced recovery after maintenance of neuromuscular block with Org 9487 (rapacuronium) or rocuronium following an initial dose of Org 9487.
    McCourt KC; Mirakhur RK; Lowry DW; Carroll MT; Sparr HJ
    Br J Anaesth; 1999 May; 82(5):755-6. PubMed ID: 10536556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molar potency is predictive of the speed of onset of neuromuscular block for agents of intermediate, short, and ultrashort duration.
    Kopman AF; Klewicka MM; Kopman DJ; Neuman GG
    Anesthesiology; 1999 Feb; 90(2):425-31. PubMed ID: 9952148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.